Johnson & Johnson has been told to pay $257.7 million by a jury in Louisiana for claiming that its antipsychotic Risperdal was superior to similar drugs and downplaying its link to diabetes.
J&J intends to appeal the decision. Spokesman Michael Heinley told Bloomberg that “we believe the jury was not appropriately instructed on applicable legal standards and that critical and highly relevant evidence was excluded".
1 comment:
Glaxo whistle-blower gets $96 million.
The case with the Zyprexa scandal is that Eli Lilly drug company pleaded guilty to criminal wrongs ("viva Zyprexa" campaign) the Zyprexa saga was rotten through and through.
Eight Lilly EMPLOYEES got millions each as supposed informant 'whistle blowers'.Lawyers on BOTH sides got millions and millions......most patient claimants who got sick are 'mentally challenged' and less able to advocate for themselves.
The Class action Lawsuits in the US had payouts of $85,000 BUT the lawyers got 45 percent and then the govt got most of the rest for having to take care of the victim/patients medical expenses.Soooo,,,,$85K turned into about $9,000 for Zyprexa claimants many had their food stamps and other state benefits taken away because of their *windfall profit* making them worse off in the end.
*
Daniel Haszard Zyprexa victim activist and patient who got diabetes from it. http://www.zyprexa-victims.com
Post a Comment